Navigation Links
Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
Date:3/19/2013

ing. We look forward to evaluating OMS527 in humans, and we are advancing through toxicology studies in preparation for clinical trials later this year."

About Omeros' PDE7 Programs
Omeros' phosphodiesterase 7 (PDE7) program is based on its discoveries of previously unknown links between PDE7 and any addiction or compulsive disorder and between PDE7 and any movement disorders, such as Parkinson's disease. PDE7 appears to modulate the dopaminergic system, which plays a significant role in regulating both addiction and movement. Omeros believes that PDE7 inhibitors could be effective therapeutics for the treatment of addiction and compulsive disorders as well as movement disorders. Data generated in preclinical studies support both of these potential indications. Omeros also believes that it controls the worldwide rights to any PDE7 inhibitor for the treatment of any movement disorder, including Parkinson's disease, restless leg syndrome and Huntington's disease.  Omeros has licensed its PDE7 inhibitors from Daiichi Sankyo Co., Ltd. for worldwide exclusivity in the fields of movement disorders, addictions and compulsive disorders.

About Addiction
Addiction is a significant medical problem with major socioeconomic impact. In the United States alone, the total socioeconomic cost of addiction is estimated at $484 billion per year, which is more than 60% greater than that for cancer and diabetes combined. Sales of current addiction medications exceed $4.4 billion worldwide, though they are either largely ineffective or have significant side-effects.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) ... Market (Indwelling or Foley Catheters, Intermittent Catheters and Male ... Share, Growth, Trends and Forecast 2014 - 2020" ... present, the global market for urinary catheters is experiencing ...
(Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... personalized immune therapies for operable and inoperable solid tumor cancers, ... at the 7 th Annual Phacilitate Immunotherapy Forum in ... presentation at Phacilitate will take place on January 26 at ...
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced ... for the compounding, packaging and distributing of its naltrexone tablets. ... the United States . KRS Global ... naltrexone tablets in various strengths for individual patients in response ...
Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... COSTA MESA, Calif., Feb. 10, 2011 Renaissance Surgical Arts ... outpatient surgery center in the Western United States to offer ... device used in the TARGIT-A multicenter human clinical trial that ... certain women with early breast cancer. IORT ...
... Feb. 10, 2011 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... Vice President, Finance and Chief Financial Officer. Mr. Hoffman, who has ... his current role at Arena until the reporting of the company,s ... year ended December 31, 2010. "We thank Robert for ...
Cached Medicine Technology:Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 3Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer 2Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer 3
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
(Date:1/22/2015)... a new blog post explaining the importance of keeping a first ... an auto insurance policy . , Clients who driver safer ... vehicle insurance policies. The safety a vehicle offers from its driver ... this, drivers should always carry a first aid kit in their ...
(Date:1/22/2015)... January 22, 2015 State Forestry Institute ... management system with support from GEOSYSTEMS, a dedicated Hexagon ... solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... as well as point clouds and documents. This effort ...
Breaking Medicine News(10 mins):Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... AMSTERDAM and SAN DIEGO, July 15 Royal Philips (AEX: ... reached an agreement to acquire the assets of InnerCool Therapies Inc., ... management of a patient,s body temperature. InnerCool, a wholly-owned subsidiary of ... acquired in an asset purchase transaction for US $11.25M, as well ...
... Discovery could pave the way for future targeted treatment, ... of circulating blood cells appear to be important predictors ... researchers. , They measured levels of circulating endothelial cells ... cancer, 22 children with metastatic cancer and 20 healthy ...
... , , , NORTH ... hot flashes, night sweats and mood swings, but a recent ... severity can have an overwhelmingly negative impact on every aspect ... by Duramed Pharmaceuticals, Inc., (now Teva Women,s Health, Inc.) a ...
... today the recipients of the 2009 World Federation of ... hemophilia education and training to nurses in developing countries ... supply. Three recipients were selected out of a pool ... , "Worldwide, about 70 percent of people with hemophilia ...
... , , SAN ... CADX ) announced today that its New Drug Application (NDA) for ... acute pain and fever in adults and children, has been accepted ... designated for Priority Review. Priority Review is granted to those products ...
... ... Daily Shot. It provides a "daily dose of sanity" for women dealing with ... , ... York, NY (PRWEB) July 15, 2009 -- FertilityAuthority introduces "The Daily Shot," an e-newsletter ...
Cached Medicine News:Health News:Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management 2Health News:Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management 3Health News:Rare Cells Linked to Pediatric Cancers 2Health News:Menopause Is More Than A Hot Flash 2Health News:Menopause Is More Than A Hot Flash 3Health News:Menopause Is More Than A Hot Flash 4Health News:Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 2Health News:Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 3Health News:Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship 4Health News:Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever 2Health News:Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever 3Health News:Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever 4Health News:FertilityAuthority Introduces E-Newsletter, The Daily Shot 2
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
Medicine Products: